Skip to Content

Nascent Biotech Inc NBIO Stock Quote

| Rating as of


Market Open

| Currency in USD

  • Last Close 0.12
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style
  • Day Range 0.11  –  0.12
  • Year Range 0.03  –  0.43
  • Market Cap 18.2407 Mil
  • Volume / Avg 53,683.0 /  221,883.1
  • Price / Sales
  • Price / Book
  • Forward Div Yield 3.33%
  • Trailing Div Yield

Morningstar‘s Stock Analysis NBIO

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics NBIO

Company Profile NBIO

Business Description

Nascent Biotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is focused on the development and delivery of human antibodies and cytokine responses to the treatment of cancer. The company's products include Pritumumab, CLNH5, and MultiPharm. The company is actively engaged in the development of Pritumumab which would be used for the treatment of brain cancer and pancreatic cancer. The company is also exploring the use of Pritumumab against other viruses.

631 US Hwy 1, Suite 407
N Palm Beach, FL, 33408
Industry Biotechnology

Competitors & Peers NBIO

Morningstar does not cover competitors or peers for this firm.

FAQs for Nascent Biotech Inc Stock

No. NBIO does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

NBIO’s market cap is 18.24 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

NBIO’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare NBIO’s historical performance against its industry peers and the overall market.